Snyman, Jacques R.
Gumedze, Freedom
Jones, Erika S. W.
Alaba, Olufunke A.
Tsabedze, Nqoba
Vira, Alykhan
Ntusi, Ntobeko A. B. http://orcid.org/0000-0003-2347-7883
Funding for this research was provided by:
Servier
University of Cape Town
Article History
Received: 25 April 2023
Accepted: 9 August 2023
First Online: 21 September 2023
Declarations
:
: Jacques R. Snyman has received honoraria from Servier. Freedom Gumedze has received honoraria from Servier. Erika S. W. Jones has received sponsorship and honoraria from Servier and Pharmadynamics. Olufunke A. Alaba has received honoraria from Servier. Nqoba Tsabedze has received consultation fees from Novartis Pharmaceuticals, Novo Nordisk, Boston Scientific, Pfizer, Servier, Phillips, Takeda, AstraZeneca, Acino Health Care Group and Merck; and educational and travel grants from Medtronic, Biotronik, Boston Scientific and Vertice Health Care Group. Alykhan Vira is an employee of Quantium Health South Africa. Ntobeko A. B. Ntusi acknowledges support from the South African Medical Research Council (SA-MRC), National Research Foundation and the Lily and Ernst Hausmann Trust; unrestricted educational grants from Siemens, General Electric, Philips and CVI42; and honoraria from Novo Nordisk and Servier.
: All work was carried out in accordance with the Helsinki Declaration of 1964, and its later amendments. Ethics approval was obtained by Professor Ntobeko A. B. Ntusi from the University of Cape Town faculty of Health Sciences Human Research Ethics Committee (HREC: 778/2021) for the usage of the dataset. Informed consent was not required for this study.